Summary. A reliable method has been developed for the determination of total serum T3, dialyzable fraction (DFT3), and absolute concentration of free T3 (AFT3). Total T3 values (mean ± SD) were: healthy euthyroid subjects, 0.33 ± 0.07 /Ag per 100 ml; hyperthyroid patients, 0.71 ± 0.1 jug per 100 ml; hypothyroid, 0.10 + 0.03 jug per 100 ml. Values (mean ± SD) for DFT3 in these groups were 0.46 + 0.14%, 0.78 ± 0.17%, and 0.16 ± 0.08%, respectively. Calculated values for AFT3 were: 1.51 + 0.4 m/tg per 100 ml, 5.00 ± 0.6 mug per 100 ml and 0.24 ± 0.1 mug per 100 ml, respectively. Dilution of serum before dialysis lowered estimated DFT3 values. Enrichment of serum with labeled T3 in the range examined did not affect DFT3. However, DFT3 was increased by addition of Merthiolate to serum in concentration 1: 10,000 due to displacement of T3 from thyroxine-binding globulin to albumin. The data suggest that triiodothyronine may play a considerably more important role in normal and pathological physiology, as evidenced by kinetic analysis using these data. A metabolic role for T3 equal to that of T4 is indicated.
Introduction
The present report describes a method which permits quantitation by weight of total and of dialyzable triiodothyronine. Preliminary results are presented from euthyroid subjects and from hyperand hypothyroid patients. Some of the factors which influence the determination have been analyzed.
Triiodothyronine was discovered in 1952 and was suggested as a second thyroid hormone (1, 2) . Knowledge however is still limited about the concentrations that exist in human serum. In a few reports (3) (4) (5) (6) , triiodothyronine (T3) was esti-mated by means of a radiochemical method and the results expressed as a percentage of total protein-bound iodine in serum. The concentration of hormone was also determined by a chemical method (7, 8) . Unfortunately, the catalytic activity of T3 in the Sandell-Kolthoff reaction is weak (9) , and the low concentrations present in normal plasma make the accuracy of these determinations doubtful.
Recent workers (10) (11) (12) have postulated that only the unbound portion of the thyroid hormones is physiologically active. Thus, the difficulty which exists in determining total T3 becomes a limiting factor in estimating absolute concentrations of the free hormone. To date, only the percentage of total T3 considered to be free has been measured, by means of dialysis (12, 13) or dextran gel filtration (14) .
Methods L-Triiodothyronine-1'5I (T3 "'I) and L-triiodothyronine-"~I (T3 "'I) in propylene glycol solution were obtained from Abbott Laboratories 1 with specific activity of at least 30 mc per mg. All preparations, as well as the stable compounds used as standards, were tested for purity either by paper chromatography (descending phase), or by thin-layer chromatography (TLC) (ascending phase), as described below. Samples containing other iodo-compounds besides T3 were purified further by chromatography until a single spot, T3, was present on TLC. T3 thus isolated was eluted and dissolved in 0.125% solution of human albumin to a concentration of 0.5 1Ag of labeled T3 per 10 ml.
In addition to the labeled materials, the following stable chemicals were used: thyroxine (T4), triiodothyronine (T3), diiodotyrosine, monoiodotyrosine2; tertiary butanol 3; tertiary amyl alcohol 3; acetone 3 (spectroanalyzed); chloroform 3; sulfuric acid 3; sodium hydroxide 3; bromothymol blue 3; ammonium hydroxide 3; magnesium chloride3; mono-and dibasic potassium phosphate3; Merthiolate powder 4; Tris maleate buffer pH 8.65; Veronal buffer pH 8.6.6 TLC silica gel plates, type K 301-R2, were obtained from a commercial source,7 as were Visking cellulose casing 8 and Sephadex G-25 and Sephadex LH-20.9
Healthy subjects and patients in the Thyroid Clinic or admitted to the hospital were studied. The patients had either hyperthyroidism or hypothyroidism, or were euthyroid on replacement therapy subsequent to total thyroidectomy. Diagnoses were verified both by clinical examination and by routine laboratory tests. Blood was obtained and centrifuged within an hour or two. Sera thus obtained were either processed immediately or were deep frozen for later use.
Extraction of serum. 10-ml samples of serum were used, to which T3 'I, 0.001-0.002 Ag, was added as a recovery standard. The mixture was placed in a 500 ml separatory funnel, 200 ml of a freshly prepared mixture of methanol: chloroform (1: 1 v/v) was added, and the contents were shaken for 3 min. Then 50 ml 0.03 N sulfuric acid was introduced and the whole mixed by further shaking for 5 min. Equilibration of the water-solvent system was permitted for 10 min. Three distinct phases separated out: (a) a chloroform phase containing most of the serum lipids at the bottom; (b) a precipitated protein phase in the middle; and (c) an acidified methanolwater phase at the top, containing most of the iodocompound content.
The bottom phase was removed and saved. The remaining two phases were mixed together and filtered through a Buchner funnel (Whatman paper No. 1) into a round bottom flask. The chloroform phase was then reintroduced into the separatory funnel and washed with 100 ml of methanol: H20 (1: 1 v/v) by thorough mixing.
Separations were seemingly complete after 10 min. The 2 Mann Research Laboratories, New York, N. Y. 3 Fisher Scientific Company, New York, N. Y. 4 Eli Lilly & Co., Indianapolis, Ind. 5 10 and by comparison with the position of standards applied to the same plate or paper and developed with arsenious acidceric sulfate system as described elsewhere (15) . T3
10Ansco high speed X-ray films were used for radioautography.
spots were cut out and eluted with methanol: ammonia (99: 1 v/v) by descending flow technique in a Gelman chromatocab." 1 Approximately 5 ml of the eluate was collected in 15-ml plastic centrifuge tubes and evaporated to dryness under air at 370 C.
Quantitation of total T3. The known competition for T4 which takes place between serum thyroxine-binding globulin (TBG) and added dextran gel (16) has been used as the basis for determining the amount of T4 in serum (16) . The Murphy-Pattee procedure for T4 had to be slightly modified in order to be usable for T3 measurement. Dry Sephadex G-25, 250 mg, was allowed to swell in distilled water and was then packed in a column. The column-packing procedure was the same as that described above for Sephadex LH-20. Before use, the column was equilibrated with 20 ml Veronal buffer, pH 8.6, ionic strength 0.075. "Isotope solution" (16) of T3 'l'I was prepared as follows. 0.2 lsg of previously purified T3 131I, 6 ml of pooled serum, and 2 ml of propylene glycol were mixed and the whole sample was diluted to 100 ml with Veronal buffer, pH 8.6, as above. Working solutions of stable T3 which contained the hormone in concentrations of from 0.0025 to 0.060 ,ug per 1 ml of methanol: ammonia (99: 1 v/v) were used to prepare a standard curve after correction for water of crystallization. The weight of standard T3 dissolved was that amount wanted X 1.089.
1 ml of isotope solution containing T3 'I was added to the dry eluate from TLC or paper obtained above and the mixture incubated at 370 C for 30 min. After incubation, the sample was allowed to cool to room temperature and radioactivity was assayed in a Packard Autogamma welltype scintillation counter. The contents of the tube were then transferred quantitatively with Veronal buffer to a Sephadex G-25 column. The protein-bound fraction was eluted as previously described (16 tion of iodoamino acids on paper and silica gel plates.
R. values in our systems for iodocompounds are shown in Table I . The locations on the chromatograms of stained standard T3 and of labeled T3 from serum extracts coincided exactly, as revealed by radioautography (Figures 1 and 2) . Elution of T3 was accomplished as stated above by descending flow, whether from paper or silica gel plate. This step was fast and efficient, and permitted the hormone to be obtained in a small volume of methanol. Losses from chromatographic separation and elution averaged only 8.4 ± 1.2%. Thus, final recovery of T3 for the entire procedure was 67.4 ± 8.1%.
The standard curve constructed for the quantitative determination of T3 in the last step of the method (Figure 3 ) was found to be suitable for low, medium, or high T3 concentrations, when 10-ml samples of serum were extracted. As in the method for determination of T4 (16), the rise and slope of the standard curve varied with changes in amount of serum employed to make up the solution containing labeled standard T3, and in amount of Sephadex G-25 used to pack the column. Optimum results were obtained with 6 ml of serum diluted 1: 16, and 250 mg of Sephadex per column. As with T4, increases in temperature raised the amount of T3 bound to Sephadex.
The addition of as little as 0.001 jug of T4 to the final extract produced a significant increase (roughly 0.01 ug of T3 per 100 ml) in the value determined for total T3. Thus, T4 contamination during the procedure was insured against by completely adequate separation of the iodocompounds on the chromatograms. As stated above, the reliability of the chromatographic separation was checked repeatedly, by rechromatography of the eluted T3 material from the original paper or silica gel plate chromatograms; only a single T3 spot was found. Also, no significant trailing of the appropriate labeled compounds into the neighboring T3 or T4 areas was found (see Ta~ble II) and two values for serum T3 from a thyroidectomized patient on T4 replacement therapy were negligible (see Results). Serum determinations. The reproducibility and precision of the over-all method for the determination of T3 in serum was checked in two ways. First, 10 determinations were made on aliquots of a single pool of human serum; second, determinations were made in duplicate with aliquots from the same serum pool enriched by the addition of stable T3 to provide concentrations of 0.01, 0.02, and 0.04 ,ug per 10 ml of serum. As shown in Table III , reproductibility of the determinations was good at each of the four concentrations employed.
The reliability of the procedure for determining the dialyzable T3 fraction (DFT3) was also evaluated. Studies were made of the characteristics of the system during equilibrium dialysis; of the effect of added Merthiolate as a preservative;
and of the effect of dilution of the test serum. The results are depicted in Figure 4 . Between 16 and 36 hr of dialysis, DFT3 was almost constant, suggesting that equilibrium was achieved by 16 to 20 hr.
The effect of Merthiolate was tested in the 1: 10,000 concentration used for dialyzable T4 determination (17) (Figure 4 ). (Table IV) . The addition of as much as 0.1 jug of stable T3 (as labeled T3) per 100 ml of serum had no detectable effect upon the final results.
Clinical values. Results from the determinations of total and free T3 in sera of healthy euthyroid subjects and of patients with hyper-and hypothyroidism are presented in Figure 5 . pronounced differences from normal than did total T3. In the normal group, a mean ± SD value was determined for AFT3 of 1.51 ± 0.4 mug per 100 ml of serum. In the hyperthyroid patients, the mean AFT3 value was slightly more than three times greater than normal, but in the hypothyroid patients, was approximately only a fifth of normal. The mean + SD DFT3 for the normal subjects was 0.464±0.14%; for the hyperthyroid group, 0.78 + 0.17%o; and for the hypothyroid group, 0.16 ± 0.08%. Discussion A major obstacle to the establishment of a reliable method for determination of total and dialyzable T3 in human serum has been the low concentrations which are present. We therefore used 10 ml of serum. Such a volume introduces technical problems, for the large amounts of both serum lipids and salts recovered with extraction interfere seriously with chromatographic separation of the iodocompounds, especially on TLC (19) . However, an efficient and simple extraction procedure was developed which has permitted virtually complete removal of such interfering compounds.
Also, to help increase the accuracy of the determination, we added T3 125I to the serum before extraction. Final recovery for each sample could thus be calculated and radioautography could be used to mark precisely the T3 position. Although the weight of T3 127I introduced with the label was very low, the value was subtracted from the final serum result.
A modified (8) Sandell-Kolthoff method, and Barker's distillation procedure (20) were employed early in the study to determine amounts of T3 and other iodocompounds in eluates from the chromatograms. The results obtained for T3 were not reproducible despite the low "binding protein" affinity of T3 (10) compared to that of T4.
However, by the use of the Murphy-Pattee procedure for T4 determination (16) , with the modifications above, a high degree of accuracy was obtained. Control of three important variables must be achieved. This can be insured by: (a) use of a 1: 16 dilution of serum only, in the "isotopic solution"; (b) adequacy of chromatographic separaration of T3 from T4; and (c) constancy of the amount of Sephadex used for the competitive binding step.
Several factors which have been found to interfere with determination of the dialyzable fraction of T4 interfere equally with the determination of the dialyzable fraction of T3. One is the time at which equilibrium is reached, a minimum of 16 hr. This value is the same as that for T4 (12, 17) . Second is the concentration of Merthiolate introduced to prevent bacterial growth during dialysis. (12, 17) . Last, impurities in the labeled T3 material may seriously affect determination of total T3 and DFT3. Both T3 125I and T3 131I preparations, as delivered, were regularly contaminated with T4. Thus, preliminary purification is essential.
Two reports are available in which normal total T3 iodine concentration was determined by chemical means. Reported values were 0.14 ug per 100 ml (7) and 0.26 ,ug per 100 ml (8), or 0.23 and 0.43 ,g per 100 ml, as T3. Our study gives a value of 0.33 ,g + 0.07 per 100 ml of serum, as T3.
A T3: T4 ratio, as T3 and T4, in the euthyroid group was calculated from our data and a value, 0.052, found. This corresponds well with the figure, 0.046, reported from an estimate of T4 and T3 iodines made with radioisotopes (6) .
The increase in total T3 seen in hyperthyroidism, and the decrease in hypothyroidism resemble the well-known changes in total T4 reported for these conditions (8) . However, the changes in total T3 appear to be more pronounced.
Previous estimates of DFT3 have been in good agreement (12, 13) . A DFT3: DFT4 ratio of between 8 and 10 has been calculated. Our study, however, has permitted, as well, determination of the absolute concentration of free T3 (AFT3). A normal ratio, AFT3: AFT4, of approximately 1: 3 has been observed. The ratio became increased in hyperthyroidism and decreased in hypothyroidism. AFT4 was determined by us by methods outlined in the studies just mentioned (12, 13) .
The good correlation found to exist in normal sera between total T3 concentration and AFT3 supports the concept that the thyroid hormones and the thyroxine-binding proteins of serum in vitro are in a reversible binding equilibrium (10) . However, correlation was less significant when hyper-and hypothyroid sera were studied. A similar observation was made when total T4 and AFT4 were examined in these disorders (12) . Whether T3 binding occurs in vtivo has been questioned (21) .
Recent work has shown that the volume of distribution of T3 131I is about three times that of labeled T4 and the degradation rate five times that of labeled T4 (22 60 ,ug of iodine daily for degradation of T4 or about 100 MAg of T4 daily. That the ratio of T4 to T3 is much higher in the thyroid than 2: 1 implies preferential secretion of T3. Such preferential secretion from the thyroid might well explain in whole or in part the "iodine leak" from the thyroid indicated by kinetic analysis (22, 23) .
